Hanmi Pharm Reports Operating Profit of 10.6 Billion KRW in Q2, Down 54% Year-on-Year

[Asia Economy Reporter Geum Bo-ryeong] Hanmi Pharm announced on the 29th that its consolidated operating profit for the second quarter of this year was preliminarily estimated at 10.64 billion KRW, down 54.1% compared to the previous year.

During the same period, sales amounted to 243.411 billion KRW, a decrease of 10%.